[1]BRIGADEAU F,LACROIX D.Natural history and outcomes of atrial fibrillation[J].Rev Prat,2013,63(2):193-197.
[2]刘少稳.心房颤动的认识和治疗进展[J].上海医学,2014,37(3):191-195.
[3]别立展,赵丹丹,黄春恺,等.心房颤动的流行病学研究现状及进展[J].现代生物医学进展,2015,15(13):2562-2566.DOI:10.13241/j.cnki.pmb.2015.13.044.
BIE L Z,ZHAO D D,HUANG C K,et al.The status and research progress on the epidemiology of atrial fibrillation[J].Progress in Modern Biomedicine,2015,15(13):2562-2566.DOI:10.13241/j.cnki.pmb.2015.13.044.
[4]SAMUEL L.Special abstract issue of the 12th Annual Congress of the European Cardiac Arrhythmia Society(ECAS)[J].J Interv Card Electrophysiol,2016,459(3):233-333.DOI:10.1007/s10840-016-0108-7.
[5]ZENG B Y,BAI J F.Recent advances in radio frequency ablation techniques of atrial fibrillation [J]. Journal of Shanghai Jiaotong University(Science),2014,19(6):702-705.
[6]闫静静,秦明照.中国老年心房颤动患者抗凝治疗现状及分析[J].中国全科医学,2018,21(27):3285-3289.
YAN J J,QIN M Z.Anticoagulation therapy for Chinese elderly patients with atrial fibrillation[J].Chinese General Practice,2018,21(27):3285-3289.
[7]胡大一,黄峻,马长生,等.心血管内科学高级教程[M].北京:中华医学电子音像出版社,2016:352-354.
[8]宋元申,逯若逸,韩宏光.心动过速性心肌病的研究与治疗进展[J].心血管外科杂志(电子版),2016,5(2):77-80.
[9]BRUNO T N,MARCOS F M,KATASHI O,et al.Reminder of important clinical lesson Tachycardia-induced cardiomyopathy[J].BMJ Case Reports,2012,10(1136):1-4.DOI:10.1136/bcr-2012-006587.
[10]JEONG Y H,CHOI K J.Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy[J].Clin Cardiol,2008,31(4):172-178.DOI:10.1002/clc.20161.
[11]易梦.15例儿童心动过速性心肌病的临床分析[D].重庆:重庆医科大学,2014.
[12]FENELON G,WIJNS W,ANDRIES E,et al.Tachycardiomyopathy:mechanisms and clinical implications[J].Pacing Clin Electrophysiol,1996,19(1):95-106.
[13]沈才杰,陈晓敏,何斌,等.心房颤动致心动过速性心肌病及导管射频消融术后左心室射血分数恢复的影响因素分析[J].中国介入心血管病杂志,2013,21(1):34-40.
SHEN C J,CHEN X M,HE B,et al.Influential factors of tachycardia cardiomyopathy induced with atrial fibrillation and reversibility of left ventricular ejection fraction after radiofrequency catheter ablation[J].Chin J Intervent Cardiol,2013,21(1):34-40.
[14]APPLE F S,PEARCE L A,SMITH S W,et al.Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events[J].Clin Chem,2009,55(5):931-936.